Eli Lilly and OpenAI forge pioneering alliance to combat antimicrobial resistance

Eli Lilly and Company (NYSE: LLY) has entered into a partnership with OpenAI to harness generative AI for the discovery of new antimicrobials, aiming to ... Read More